Supplementary Data from Histone methyltransferase NSD2 activates PKCα to drive metabolic reprogramming and lenalidomide resistance in multiple myeloma | Synapse
September 16, 2024
Supplementary Data from Histone methyltransferase NSD2 activates PKCα to drive metabolic reprogramming and lenalidomide resistance in multiple myeloma
Key Points
Key points are not available for this paper at this time.